Page 5 - Les meilleurs doctors traitant la maladie suivante : Cancer de l'estomac - TOP -144 des médecins

Expert en chirurgie laparoscopique pour le cancer de l'estomac – le Dr Mansfeld dirige le département de médecine gastro-intestinale de l'hôpital Asklepios Wandsbek.

• Consultant principal spécialisé en chirurgie abdominale et colorectal
• Membre de l'European Board of Surgeons
• Certifié en reconstructions complexes de la paroi abdominale
• Accent particulier sur les techniques minimalement invasives

Le Dr Ozden apporte plus de 20 ans d'expérience en médecine interne et en oncologie médicale, avec une formation spécialisée de la prestigieuse faculté de médecine Cerrahpaşa de l'université d'Istanbul.

• Avoir terminé une surspécialisation en oncologie médicale à la faculté de médecine de l'université de Kocaeli
• Posséder une vaste expérience en médecine interne dans plusieurs hôpitaux
• Être diplômé du programme médical en anglais de l'université d'Istanbul

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Spécialisé dans le cancer gastrique et la chirurgie oncologique, proposant des traitements ciblés aux hôpitaux Büyük Anadolu.

• Être expert en chirurgies du pancréas et des voies biliaires
• Pratiquer des chirurgies bariatriques et métaboliques
• Être qualifié pour les interventions sur le cancer du colon et de la thyroïde

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Le Dr Joseba Rebollo Liceaga apporte plus de 30 ans d'expérience dévouée en oncologie médicale, se spécialisant dans le cancer de l'estomac à Quirónsalud Alicante.

• Ancien chef du service d'oncologie de la Clínica San Miguel de Navarra et de l'Hospital General de Villalba
• Résidence et formation spécialisée à la Clínica Universidad de Navarra
• Rédiger des recherches sur l'électrochimiothérapie et les traitements multidisciplinaires du cancer
• Suivre plusieurs cours de perfectionnement en oncologie multidisciplinaire

Dr. David Kuczer is a specialist in radio-oncology with many years of experience in cancer diagnosis and treatment. He offers fast access to precise radiotherapy based on current scientific standards.

He is a member of the Cancer Center at the Vienna Private Clinic. He presents each patient to the in-house tumor board. This allows an interdisciplinary discussion by an internationally renowned team and helps select the best treatment.

All radiation treatments are provided in close cooperation with Amethyst Radiotherapy at the Vienna Private Clinic.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Chef du service d'onco-radiothérapie au Samsung Medical Center, le Pr Lim est spécialisé dans le traitement du cancer de l'estomac, en mettant l'accent sur la radiothérapie de précision.

• Formation à l'hôpital universitaire national de Séoul et au Samsung Medical Center
• Spécialisation dans les tumeurs de l'estomac, pancréatobiliaires et du SNC
• Direction d'un département d'onco-radiothérapie de premier plan

Plus de 15 000 interventions chirurgicales pratiquées – le Dr de Lacy est un pionnier de la chirurgie gastro-intestinale mini-invasive à l'Hospital Quiron Barcelona.

• Réaliser plus de 1 000 interventions par an à l'aide de techniques laparoscopiques et robotiques
• Première mondiale pour l'ablation de la vésicule biliaire par la bouche – sortie des patients en quelques jours
• Fondateur de la technique TaTME pour la chirurgie du cancer du rectum
• Président de l'Association des chirurgiens-endoscopistes en Europe

Le Dr Leng Yin est spécialisé dans le traitement des cancers du foie, de la vésicule biliaire, de l'estomac, du pancréas et des intestins à l'hôpital Fuda Cancer.

• Oncologue expérimenté ayant travaillé aux hôpitaux Bumrungrad International et Royal Siriraj
• Membre de l'Association chinoise de lutte contre le cancer
• Expertise dans le diagnostic et le traitement des cancers gastro-intestinaux

Le Dr Gutman se spécialise dans la chirurgie du cancer de l'estomac au centre médical Assuta.

• Oncochirurgien expérimenté spécialisé dans les cancers gastro-intestinaux
• Travailler au centre médical Assuta – un établissement d'oncologie de premier plan
• Élaborer des plans de traitement personnalisés pour chaque patient

Chef adjoint du département d'oncologie du centre médical Rambam – un rôle de premier plan dans le traitement du cancer de l'estomac.

• Se spécialiser en oncologie gastro-intestinale
• Travailler dans l'un des meilleurs centres médicaux d'Israël
• Se concentrer sur des approches de traitement avancées